CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase II Study of Niraparib in Combination With EGFR Inhibitor Panitumumab in Patients With Advanced Colorectal Cancer
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03983993
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:28:42.317622+00:00
- Published At
- 2025-04-09T00:00:00+00:00
- Record Updated At
- 2026-01-05
- Results Posted At
- 2025-04-09
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Advanced Microsatellite Stable Colorectal Carcinoma", "Metastatic Microsatellite Stable Colorectal Carcinoma", "Microsatellite Stable", "RAS Wild Type", "Stage IV Colorectal Cancer AJCC v8", "MSI-H Colorectal Cancer"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-01-05"- protocolSection.identificationModule.nctId
"NCT03983993"- protocolSection.identificationModule.officialTitle
"A Phase II Study of Niraparib in Combination With EGFR Inhibitor Panitumumab in Patients With Advanced Colorectal Cancer"- protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2025-04-09"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.